Johnson & Johnson, Crucell biotech announce takeover
Wednesday, October 6, 2010 - 04:01
in Mathematics & Economics
Pharmaceutical and health care giant Johnson & Johnson has reached a deal with Dutch biotechnology vaccine group Crucell to buy 82.5 percent of Crucell for about 1.75 billion euros, the two firms said on Wednesday.